Systemic reserve dysfunction and contrast-associated acute kidney injury following percutaneous coronary intervention

Mi-Jeong Kim1,2,3, Doo Soo Jeon1,2,3, Youngchul Ahn1

  • 1Department of Cardiology, Incheon St. Mary's Hospital, The Catholic University of Korea, Incheon, Republic of Korea.

Plos One
|March 5, 2024
PubMed

Insights

Neutrophil gelatinase-associated lipocalin (NGAL) levels before and after percutaneous coronary intervention (PCI) can help predict contrast-associated acute kidney injury (CA-AKI). This NGAL combination also indicates long-term mortality risk in PCI patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Biomarkers

Background:

  • Contrast-associated acute kidney injury (CA-AKI) is a complication of percutaneous coronary intervention (PCI).
  • Risk factors include patient characteristics and contrast media administration.
  • The role of neutrophil gelatinase-associated lipocalin (NGAL) in CA-AKI post-PCI is not well understood.

Purpose of the Study:

  • To investigate the diagnostic and prognostic value of NGAL in CA-AKI following PCI.
  • To assess the association between NGAL levels and long-term mortality in these patients.

Main Methods:

  • Prospective enrollment of patients undergoing PCI.
  • CA-AKI defined by serum creatinine increase within 48-7 days post-PCI.
  • Serum NGAL measured pre-PCI and 6 hours post-PCI.
  • Patients grouped based on NGAL levels relative to the 75th percentile.

Main Results:

  • CA-AKI occurred in 6.4% of patients.
  • Combined pre- and post-PCI NGAL levels were independently associated with CA-AKI occurrence.
  • NGAL groups showed significant differences in all-cause mortality over 29 months.
  • Contrast administration had a limited role in CA-AKI development.

Conclusions:

  • Combined pre- and post-PCI NGAL levels can aid in risk-stratifying CA-AKI and long-term mortality.
  • Systemic reserve deficiency, not contrast alone, likely drives CA-AKI.
Abstract